Milwaukee-based PROMISS Diagnostics raises $400,000

Funding round led by Wisconsin Alumni Research Foundation

PROMISS Diagnostics, Inc., a Milwaukee-based company developing an early-detection ovarian cancer test, has raised $400,000 in a seed round of funding, the company announced Friday. The funding round was led by the Wisconsin Alumni Research Foundation with additional investments from Cream City Venture Capital, Northwestern Mutual’s $5 million venture fund. PROMISS Diagnostics is a venture-stage

Already a subscriber? Log in

To continue reading this article ...

Subscribe to BizTimes today and get immediate access to our Insider-only content and much more.

Learn More and Subscribe Now

Sign up for the BizTimes email newsletter

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

What's New

BizPeople

Sponsored Content

Stay up-to-date with our free email newsletter

Keep up with the issues, companies and people that matter most to business in the Milwaukee metro area.

By subscribing you agree to our privacy policy.

No, thank you.
BizTimes Milwaukee